Visit our country sites
- Visit our country sites
- CEVA corporate
- CEVA group web sites
Visit our Product Sites
- Visit our Product Sites
- CEVA products web sites
- CEVA ranges web sites
<
>
Ceva Develops Vectormune HVT AIV vaccine
Vaccine offers a powerful tool to fight Avian Influenza while mitigating the high risk of transmission to people.
Long awaited by poultry producers around the world, the vaccine offers a powerful tool to fight Avian Influenza while mitigating the high risk of transmission to people. AI has proven to be a major threat for the global poultry industry, disrupting international trade and inducing high levels of mortality and economical losses in infected flocks. Emerging markets especially struggle to fight and recover from the disease, and decreasing public research funds only compound the issue. Now, Vectormune HVT AIV offers an effective, safe and affordable solution.
